
|Articles|October 1, 2002
- Volume 0 0
October 2002: Rx Image One
Advertisement
Pharmacy technician Amanda Terry and pharmacist Caron Rae Oden of Adcock?s Medicine Cabinet in Atlanta, TX, are familiar with the ?writing style? of the physician who wrote this Rx, but following many attempts to figure it out they decided to call and confirm. After speaking with the nurse, and after she double-checked with the physician, the answer became clear. Is it clear to you?
Click Here For The Answer ----------->
[
N-Humulin insulin 10 cc, use as directed daily
toggle(getObject('exp1048685570_link'), 'exp1048685570');
Articles in this issue
about 24 years ago
Voriconazole (Vfend)about 24 years ago
Pharmacist with Cerebral Palsy Sues for Job Discriminationabout 24 years ago
Almonds Can Cut Cholesterolabout 24 years ago
Interpependence In Health Careabout 24 years ago
Cold and Flu Season Is Hereabout 24 years ago
Drug Diversion in Veterinary Medicineabout 24 years ago
October 2002: Rx Image Twoabout 24 years ago
Benefits of Lowering Cholesterol After Heart Attackabout 24 years ago
Fish Oil Plus Statins May Be Effective as Combination Therapyabout 24 years ago
Breast-Feeding May Lower Cholesterol in AdulthoodAdvertisement
Related to this article

As Pharmacy Technician Day approaches, the CEO of the Pharmacy Technician Certification Board argues that real recognition means career ladders, consistent scope regulations, and investment in certification.

William J. Peppard, PharmD, explains how emerging suzetrigine findings after knee arthroplasty connect opioid stewardship with functional recovery and the pharmacist’s role in ensuring treatment access.

Tor Härnqvist, MD, discusses immune testing after invasive pneumococcal disease, serotype-informed vaccine selection, and pharmacists' role in supporting patients on immunoglobulin therapy.

In adults with type 2 diabetes at high cardiovascular (CV) risk, the oral GLP-1 RA also improved HbA1C and weight, with less hypoglycemia but more GI events.

In an interview with Pharmacy Times, LINKER-SMM1 study investigator Paula Rodríguez-Otero, MD, PhD, a hematologist at Clínica Universidad de Navarra in Pamplona, Spain, explains how researchers selected high-risk patients and how she weighs infections against the potential to prevent progression to active disease.

BRUIN CLL-313 showed significantly longer progression-free survival vs bendamustine plus rituximab, bringing a noncovalent BTK inhibitor to first-line care.

A behavioral walking program matched supervised aerobic training for improving asthma control in a randomized trial of physically inactive adults.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Butter, Beef Tallow, and LDL: Where Dietary Guidelines Diverge
2
Why Patients Fear Statins Will Affect Their Memory
3
Suzetrigine After Knee Replacement: Are Fewer Opioid Prescriptions Enough?
4
Orforglipron Shows CV Safety vs Insulin Glargine in ACHIEVE-4
5

